Join MySLAS Social

Fast and Label-Free Isolation of Circulating Tumor Cells from Blood: From a Research Microfluidic Platform to an Automated Fluidic Instrument, VTX-1 Liquid Biopsy System

Read this Report

Elodie Sollier Christen, Ph.D.
Co-Founder, Chief Scientific Officer
Vortex Biosciences
Menlo Park, CA (USA)


Elodie Sollier Christen received a physics engineering degree from Grenoble Institute of Technology and a Ph.D. in physics for life science from CEA LETI Minatec at Grenoble, France. Her Ph.D. was followed by post-doctoral research in the Bioengineering Department at the University of California, Los Angeles, with Professor Dino Di Carlo.

In 2012, Sollier Christen co-founded Vortex Biosciences. Sollier is now chief scientific officer and vice president research and development for Vortex Biosciences, leading the initiatives for the commercialization, research and clinical use of microfluidic devices for cancer research and diagnostics.

Her work has been featured in peer-reviewed journals, review papers, presentations in international conferences and several patents, including technologies licensed to Vortex Biosciences from UCLA. In 2017, Sollier Christen won the prestigious SLAS Innovation Award.

Sollier Christen’s expertise includes the development of new microfluidic devices for biological applications, focusing especially on blood sample preparation and analysis. She has been investigating different microfabrication approaches for transitioning from laboratory research to commercialization. 


Read more about SLAS Innovation Award winner Elodie Sollier Christen in the SLAS Electronic Laboratory Neighborhood e-zine:

Beyond the Bench: Translating Life Sciences Innovation

Liquid Biopsy: New Technology Uses a Microfluidic Vortex to Isolate Circulating Tumor Cells (CTCs) from Blood Samples

SLAS publishes two MEDLINE-indexed journals and accepts manuscripts on an ongoing basis from members and non-members.  > READ MORE

January 22, 2018